Therefore, a plenty of studies and clinical investigations were aimed at promoting plasma lipid metabolism by enhancing the activity of LCAT to find better managements choices for familial LCAT deficiency (FLD) and cardiovascular disease (58). This evidence concerns the gene LCAT and cardiovascular disorder.